Madhu Anant
Keine laufenden Positionen mehr
Profil
Madhu Anant worked as a Vice President-Regulatory Affairs at Sesen Bio, Inc. before pursuing graduate studies at the Institute of Science and a doctorate at the International University of Professional Studies.
Ehemalige bekannte Positionen von Madhu Anant
| Unternehmen | Position | Ende |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | General Counsel | - |
Ausbildung von Madhu Anant
| Institute of Science | Graduate Degree |
| International University of Professional Studies | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
